These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9688409)

  • 1. Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix.
    Felberbaum RE; Germer U; Ludwig M; Riethmüller-Winzen H; Heise S; Buttge I; Bauer O; Reissmann T; Engel J; Diedrich K
    Hum Reprod; 1998 Jun; 13(6):1660-8. PubMed ID: 9688409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medical treatment of uterine fibroids with the LHRH antagonist: Cetrorelix].
    Felberbaum RE; Ludwig M; Diedrich K
    Contracept Fertil Sex; 1999 Oct; 27(10):701-9. PubMed ID: 10605180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix.
    Flierman PA; Oberyé JJ; van der Hulst VP; de Blok S
    BJOG; 2005 May; 112(5):638-42. PubMed ID: 15842290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix.
    Gonzalez-Barcena D; Alvarez RB; Ochoa EP; Cornejo IC; Comaru-Schally AM; Schally AV; Engel J; Reissmann T; Riethmüller-Winzen H
    Hum Reprod; 1997 Sep; 12(9):2028-35. PubMed ID: 9363724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative serial MRI of the treated fibroid uterus.
    Munro KI; Thrippleton MJ; Williams AR; McKillop G; Walker J; Horne AW; Newby DE; Anderson RA; Semple SI; Marshall I; Lewis SC; Millar RP; Bastin ME; Critchley HO
    PLoS One; 2014; 9(3):e89809. PubMed ID: 24608161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presurgical short term treatment of uterine fibroids with different doses of cetrorelix acetate: a double-blind, placebo-controlled multicenter study.
    Engel JB; Audebert A; Frydman R; Zivny J; Diedrich K
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):225-32. PubMed ID: 16930803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will GnRH antagonists assist in the treatment of benign gynaecological diseases?
    Felberbaum RE; Küpker W; Diedrich K
    Reprod Biomed Online; 2002; 5 Suppl 1():68-72. PubMed ID: 12537785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nafarelin on uterine fibroids measured by ultrasound and magnetic resonance imaging.
    Williams IA; Shaw RW
    Eur J Obstet Gynecol Reprod Biol; 1990; 34(1-2):111-7. PubMed ID: 2137421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative reduction of uterine fibroids in only 16 days by administration of a gonadotrophin-releasing hormone antagonist (Cetrotide).
    Felberbaum RE; Küpker W; Krapp M; Gehl B; Ludwig M; Diedrich K
    Reprod Biomed Online; 2001; 3(1):14-18. PubMed ID: 12513885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotrophin-releasing hormone antagonists for assisted conception.
    Al-Inany H; Aboulghar M
    Cochrane Database Syst Rev; 2001; (4):CD001750. PubMed ID: 11687120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised controlled trial comparing GnRH antagonist cetrorelix with GnRH agonist leuprorelin for endometrial thinning prior to transcervical resection of endometrium.
    Bhatia K; Doonan Y; Giannakou A; Bentick B
    BJOG; 2008 Sep; 115(10):1214-24. PubMed ID: 18715405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH analogues in the treatment of uterine fibroids.
    Golan A
    Hum Reprod; 1996 Nov; 11 Suppl 3():33-41. PubMed ID: 9147100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogen deficiency causes DNA damage in uterine leiomyoma cells: a possible mechanism for shrinkage of fibroids by GnRH agonists.
    Cheng YM; Chou CY; Huang SC; Lin HC
    BJOG; 2001 Jan; 108(1):95-102. PubMed ID: 11213012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotrophin hormone-releasing hormone analogue treatment of fibroids.
    Shaw RW
    Baillieres Clin Obstet Gynaecol; 1998 Jun; 12(2):245-68. PubMed ID: 10023421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased prolactin secretion by explant cultures of fibroids from women treated with a gonadotropin-releasing hormone agonist.
    Rein MS; Friedman AJ; Heffner LJ
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1554-8. PubMed ID: 2112150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-ranging study of the luteinizing hormone-releasing hormone receptor antagonist cetrorelix pamoate in the treatment of patients with symptomatic benign prostatic hyperplasia.
    Debruyne F; Tzvetkov M; Altarac S; Geavlete PA
    Urology; 2010 Oct; 76(4):927-33. PubMed ID: 20932411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of a low gonadotrophin-releasing hormone antagonist dose in preventing premature luteinizing hormone rise during controlled ovarian stimulation.
    Tiboni GM; Palumbo P; Leonzio E; Gabriele E; Verna I; Giampietro F
    Gynecol Endocrinol; 2011 Nov; 27(11):885-9. PubMed ID: 21500992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormone.
    Kessel B; Liu J; Mortola J; Berga S; Yen SS
    Fertil Steril; 1988 Mar; 49(3):538-41. PubMed ID: 3277869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.
    Rein MS; Friedman AJ; Stuart JM; MacLaughlin DT
    Fertil Steril; 1990 Jun; 53(6):1018-23. PubMed ID: 2112489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.